-
[1]
(a) D. Ma, G. Hettiarachchi, D. Nguyen, et al. , Acyclic cucurbit[n] uril molecular containers enhance the solubility and bioactivity of poorly soluble pharma-ceuticals, Nature Chem. 4(2012)503-510;
(b) R. Tong, L. Tang, L. Ma, et al. , Smart chemistry in polymeric nanomedicine, Chem. Soc. Rev. 43(2014)6982-7012;
(c) Y. Cao, X. Y. Hu, Y. Li, et al. , Multistimuli-responsive supramolecular vesicles based on water-soluble pillar[6] arene and SAINTcomplexation for controllable drug release, J. Am. Chem. Soc. 136(2014)10762-10769;
(d) Y. Zhou, H. Li, Y. W. Yang, Controlled drug delivery systems based on calixarenes, Chin. Chem. Lett. 26(2015)825-828;
(e) Y. X. Wang, D. S. Guo, Y. C. Duan, Y. J. Wang, Y. Liu, Amphiphilic p-sulfonatocalix[4] arene as“drug chaperoneâ€for escorting anticancer, Drugs. Sci. Rep. 5(2015)9019;
(f) Y. Z. Chen, Y. K. Huang, Y. Chen, et al. , Novel nanoparticles composed of chitosan and β-cyclodextrin derivatives as potential insoluble drug carrier, Chin. Chem. Lett. 26(2015)909-913;
(g) T. Zhang, P. Huang, L. Shi, et al. , Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy, Mol. Pharmaceutics 12(2015)2328-2336;
(h) R. Jia, T. Wang, Q. Jiang, et al. , Self-assembled DNA nanostructures for drug delivery, Chin. J. Chem. 34(2016)265-272;
(i) J. Sun, J. Wang, Z. Yang, Supramolecular assembly models of siRNA delivery systems, Chin. J. Chem. 33(2015)79-89;
(j) Y. Wang, Y. Liu, Supramolecular assemblies based on p-sulfonatocalixarenes and their functions, Acta Chim. Sinica 73(2015)984-991;
(k) C. Yao, P. Wang, X. Li, et al. , Near-infrared-triggered azobenzene-liposome/upconversion nanoparticle hybrid vesicles for remotely controlled drug delivery to overcome cancer multidrug resistance, Adv. Mater. 28(2016)9341-9348;
(l) C. Wang, H. Zhang, D. Zeng, L. San, X. Mi, DNA nanotechnology mediated gold nanoparticle conjugates and their applications in biomedicine, Chin. J. Chem. 34(2016)299-307.
-
[2]
(a) R. Tanbour, A. M. Martins, W. G. Pitt, G. A. Husseini, Drug delivery systems based on polymeric micelles and ultrasound: a review, Curr. Pharm. Design 22 (2016)2796-2807;
(b) L. Zhao, J. Ding, C. Xiao, et al. , Poly (L-glutamic acid) microsphere: preparation and application in oral drug controlled release, Acta Chim. Sinica 73(2015)60-65;
(c) T. M. Allen, P. R. Cullis, Liposomal drug delivery systems: from concept to clinical applications, Adv. Drug Deliv. Rev. 65(2013)36-48;
(d) K. Wang, D. S. Guo, X. Wang, Y. Liu, Multistimuli responsive supramolecular vesicles based on the recognition of p-sulfonatocalixarene and its controllable release of doxorubicin, ACS Nano 5(2011)2880-2894.
-
[3]
(a) H. Wang, Q. Huang, H. Chang, J. Xiao, Y. Cheng, Stimuli-responsive dendrimers in drug delivery, Biomater. Sci. 4(2016)375-390;
(b) S. Zhang, J. Yang, M. Liu, et al. , Synthesis of peptide dendrimers and their application in the drug delivery system, Acta Chim. Sinica 74(2016)401-409;
(c) Y. Zhou, W. Huang, J. Liu, X. Zhu, D. Yan, Self-assembly of hyperbranched polymers and its biomedical applications, Adv. Mater. 22(2010)4567-4590.
-
[4]
(a) H. Q. Wu, C. C. Wang, Biodegradable smart nanogels: a new platform for targeting drug delivery and biomedical diagnostics, Langmuir 32(2016)6211-6225;
(b) S. Liu, Y. Zhou, F. Chen, et al. , Rheological properties, drug release behavior and cytocompatibility of novel hydrogels prepared from carboxymethyl chitosan, Acta Chim. Sinica 73(2015)47-52.
-
[5]
(a) M. Prato, K. Kostarelos, A. Bianco, Functionalized carbon nanotubes in drug design and discovery, Acc. Chem. Res. 41(2008)60-68;
(b) F. Du, J. Xu, F. Zeng, S. Wu, Preparation of a multifunctional nano-carrier system based on carbon dots with pH-triggered drug release, Acta Chim. Sinica 74(2016)241-250.
-
[6]
(a) I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev. 54(2002)631-651;
(b) P. Yang, S. Gai, J. Lin, Functionalized mesoporous silica materials for controlled drug delivery, Chem. Soc. Rev. 41(2012)3679-3698;
(c) T. Sun, Y. S. Zhang, B. Pang, et al. , Engineered nanoparticles for drug delivery in cancer therapy, Angew. Chem. Int. Ed. 53(2014)12320-12364;
(d) P. Yang, L. Wang, H. Wang, Smart supramolecular nanosystems for bioimaging and drug delivery, Chin. J. Chem. 33(2015)59-70;
(e) H. Liang, H. Tian, M. Deng, X. Chen, Gold nanoparticles for cancer theranostics, Chin. J. Chem. 33(2015)1001-1010;
(f) Y. J. Chang, X. Z. Liu, Q. Zhao, et al. , P (VPBA-DMAEA) as a pH-sensitive nanovalve for mesoporous silica nanoparticles based controlled release, Chin. Chem. Lett. 26(2015)1203-1208;
(g) X. Wang, L. Tan, Y. Yang, Controlled drug release systems based on mesoporous silica capped by gold nanoparticles, Acta Chim. Sinica 74(2016) 303-311;
(h) Z. Tang, C. He, H. Tian, et al. , Polymeric nanostructured materials for biomedical applications, Progr. Polym. Sci. 60(2016)86-128.
-
[7]
(a) J. Nicolas, Drug-initiated synthesis of polymer prodrugs: combining simplicity and efficacy in drug delivery, Chem. Mater. 28(2016)1591-1606;
(b) Z. Du, Y. Zhang, J. Ye, H. Xu, M. Lang, Synthesis and properties of the poly (ε-caprolactone)-paclitaxel prodrug, Acta Chim. Sinica 73(2015)349-356.
-
[8]
(a) D. Landesman-Milo, D. Peer, Transforming nanomedicines from lab scale production to novel clinical modality, Bioconjugate Chem 27(2016)855-862;
(b) T. M. Allen, P. R. Cullis, Adv. Drug Deliv. Rev 65(2013)36-48.
-
[9]
Cagnoni P.J., Walsh T.J., Prendergast M.M.. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients[J]. J.Clin.Oncol.,
2000,18:2476-2483.
doi: 10.1200/JCO.2000.18.12.2476
-
[10]
(a) M. Kanamala, W. R. Wilson, M. Yang, B. D. Palmer, Z. Wu, Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review, Biomaterials 85(2016)152-167;
(b) Y. Zhao, A. C. Tavares, M. A. Gauthier, Nano-engineered electro-responsive drug delivery systems, J. Mater. Chem. B 4(2016)3019-3030;
(c) S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, A review of stimuli-responsive nanocarriers for drug and gene delivery, J. Controll. Release 126 (2008)187-204;
(d) R. Cheng, F. Meng, C. Deng, H. A. Klok, Z. Zhong, Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery, Biomaterials 34(2013)3647-3657.
-
[11]
(a) L. Brunsveld, B. J. B. Folmer, E. W. Meijer, R. P. Sijbesma, Supramolecular polymers, Chem. Rev. 101(2001)4071-4098;
(b) L. Yang, X. Tan, Z. Wang, X. Zhang, Supramolecular polymers: historical development, preparation, characterization, and functions, Chem. Rev 115 (2015)7196-7239;
(c) T. Aida, E. W. Meijer, S. I. Stupp, Functional supramolecular polymers, Science 335(2012)813-817;
(d) X. Yan, F. Wang, B. Zheng, F. Huang, Stimuli-responsive supramolecular polymeric materials, Chem. Soc. Rev. 41(2012)6042-6065;
(e) D. S. Guo, Y. Liu, Calixarene-based supramolecular polymerization in solution, Chem. Soc. Rev. 41(2012)5907-5921;
(f) S. L. Li, T. Xiao, C. Lin, L. Wang, Advanced supramolecular polymers constructed by orthogonal self-assembly, Chem. Soc. Rev. 41(2012)5950-5968;
(g) X. Ma, H. Tian, Stimuli-responsive supramolecular polymers in aqueous solution, Acc. Chem. Res. 47(2014)1971-1981;
(h) E. A. Appel, J. del Barrio, X. J. Loh, O. A. Scherman, Supramolecular polymeric hydrogels, Chem. Soc. Rev 41(2012)6195-6214.
-
[12]
(a) J. Tian, L. Chen, D. W. Zhang, Y. Liu, Z. T. Li, Supramolecular organic frameworks: engineering periodicity in water through host-guest chemistry, Chem. Commun. 52(2016)6351-6362;
(b) H. Wang, D. W. Wang, Z. T. Li, Supramolecular organic frameworks (SOFs): water-phase periodic porous self-assembled architectures, Acta Chim. Sinica 73(2015)471-479;
(c) T. Wan, T. Li, From supramolecular polymers to supramolecular organic frameworks: Engineering the periodicity of solution-phase self-assembled architectures, Imaging Sci. Photochem. 33(2015)3-14;
(d) L. Chen, Y. C. Zhang, W. K. Wang, et al. , Conjugated radical cation dimerization-driven generation of supramolecular architectures, Chin. Chem. Lett. 26(2015)811-816.
-
[13]
(a) K. D. Zhang, J. Tian, D. Hanifi, et al. , Toward a single-layer two-dimensional honeycomb supramolecular organic framework in water, J. Am. Chem. Soc. 135 (2013)17913-17918;
(b) J. Tian, T. Y. Zhou, S. C. Zhang, et al. , Three-dimensional periodic supramolecular organic framework ion sponge in water and microcrystals, Nat, Commun. 5(2014)5574;
(c) J. Tian, Z. Y. Xu, D. W. Zhang, et al. , Supramolecular metal-organic frameworks that display high homogeneous and heterogeneous photo-catalytic activity for H2 production, Nat. Commun. 7(2016)11580.
-
[14]
Pfeffermann M., Dong R., Graf R.. Free-standing monolayer two-dimensional supramolecular organic framework with good internal order[J]. J. Am.Chem.Soc.,
2015,137:14525-14532.
doi: 10.1021/jacs.5b09638
-
[15]
(a) Y. Zhang, T. G. Zhan, T. Y. Zhou, et al. , Fluorescence enhancement through the formation of a single-layer two-dimensional supramolecular organic frame-work and its application in highly selective recognition of picric acid, Chem. Commun. 52(2016)7588-7591;
(b) S. Q. Xu, X. Zhang, C. B. Nie, et al. , The construction of a two-dimensional supramolecular organic framework with parallelogram pores and stepwise fluorescence enhancement, Chem. Commun. 51(2015)16417-16420.
-
[16]
Tian J., Yao C., Yang W.L.. In situ-prepared homogeneous supramolecular organic framework drug delivery systems (sof-DDSs):overcoming cancer multidrug resistance and controlled release[J]. Chin.Chem.Lett.,
2017,28:798-806.
doi: 10.1016/j.cclet.2017.01.010
-
[17]
Data from U. S. Food&Drug Administration: https: //www. cancer. gov/about-cancer/treatment/drugs.
-
[18]
(a) Y. Barenholz, Doxil®-The first FDA-approved nano-drug: Lessons learned, J. Control. Release 160(2012)117-134;
(b) F. Meng, Y. Zhong, R. Cheng, C. Deng, Z. Zhong, pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances, Nanomedicine 9(2014)487-499. C. Yao et al. /Chinese Chemica
-
[19]
Accelrys Materials Studio Release Notes, Release 5. 0, Accelrys Software Inc. , San Diego, 2008.
-
[20]
(a) J. Fang, H. Nakamura, H. Maeda, The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect, Adv. Drug Deliv. Rev. 63(2011)136-151.